Yuki Kurahashi Selected Research

Myelodysplastic Syndromes (Myelodysplastic Syndrome)

1/2021

Silylation of Deoxynucleotide Analog Yields an Orally Available Drug with Antileukemia Effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuki Kurahashi Research Topics

Disease

4	Neoplasms (Cancer) 10/2023 - 01/2020
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2023 - 01/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2021
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023
1	Carcinogenesis 10/2023
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 10/2023 - 01/2022
1	Anaplastic Lymphoma KinaseIBA 10/2023
1	alectinibIBA 10/2023
1	Decitabine FDA Link 01/2023
1	Azacitidine (5 Azacytidine)FDA Link 01/2023
1	Histones (Histone)IBA 01/2023
1	venetoclaxIBA 01/2023
1	EnzymesIBA 01/2022
1	pyrimidineIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	OR-2100IBA 01/2022
1	MethyltransferasesIBA 01/2021

Therapy/Procedure

1	Molecular Targeted Therapy 10/2023
1	Therapeutics 01/2022